Viewing Study NCT01626495


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-02-01 @ 6:05 PM
Study NCT ID: NCT01626495
Status: COMPLETED
Last Update Posted: 2020-03-23
First Post: 2012-06-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
Sponsor: University of Pennsylvania
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Cell Leukemia View
None B Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Biological: CART19 View